Sek Kathiresan MD Sek Kathiresan is Senior Vice President and Head of Obesity Research and Early Development at Eli Lilly and Company, and Chief Executive Officer and founder of Verve Therapeutics. His work focuses on cardiometabolic disease, gene editing, lifelong cholesterol reduction, and preventing heart attack. He has also held academic and clinical roles at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute.
Sek Kathiresan MD Sek Kathiresan is Senior Vice President and Head of Obesity Research and Early Development at Eli Lilly and Company, and Chief Executive Officer and founder of Verve Therapeutics. His work focuses on cardiometabolic disease, gene editing, lifelong cholesterol reduction, and preventing heart attack. He has also held academic and clinical roles at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute.
Career
Sek Kathiresan MD holds a Doctor of Medicine from Harvard Medical School and a Bachelor of Arts in History from University of Pennsylvania.